Strides Pharma Reports Net Profit Of ₹10.44 Cr In Q4FY24
Total expenses in the fourth quarter were higher at Rs 984.21 crore as compared to Rs 972.26 crore.
Aditya Kumar Badree Komandur Surabhi Loshali Barun Kumar Strides Pharma Science Ltd On Business Development
Source: freepressjournal.in